vs

Side-by-side financial comparison of MIMEDX GROUP, INC. (MDXG) and Twin Hospitality Group Inc. (TWNP). Click either name above to swap in a different company.

MIMEDX GROUP, INC. is the larger business by last-quarter revenue ($118.1M vs $82.3M, roughly 1.4× Twin Hospitality Group Inc.). MIMEDX GROUP, INC. runs the higher net margin — 12.9% vs -29.7%, a 42.6% gap on every dollar of revenue.

MiMedx is an American biomedical company based in Marietta, Georgia, founded in 2008. Using tissues from birth such as the placenta, amniotic sac, and umbilical cord, MiMedx creates skin for skin grafts for medical use.

Target Hospitality is a company that provides workforce lodging and other temporary, modular housing used for oil, gas and mining operations; large-scale events; and disaster relief. Target Hospitality is based in The Woodlands, Texas, and also has offices in Williston, North Dakota; Denver, Colorado; Calgary, Alberta.

MDXG vs TWNP — Head-to-Head

Bigger by revenue
MDXG
MDXG
1.4× larger
MDXG
$118.1M
$82.3M
TWNP
Higher net margin
MDXG
MDXG
42.6% more per $
MDXG
12.9%
-29.7%
TWNP

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
MDXG
MDXG
TWNP
TWNP
Revenue
$118.1M
$82.3M
Net Profit
$15.2M
$-24.5M
Gross Margin
83.9%
Operating Margin
17.8%
-16.2%
Net Margin
12.9%
-29.7%
Revenue YoY
27.1%
Net Profit YoY
104.2%
EPS (diluted)
$0.10
$-0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MDXG
MDXG
TWNP
TWNP
Q4 25
$118.1M
Q3 25
$113.7M
$82.3M
Q2 25
$98.6M
$87.8M
Q1 25
$88.2M
$87.1M
Q4 24
$92.9M
Q3 24
$84.1M
Q2 24
$87.2M
Q1 24
$84.7M
Net Profit
MDXG
MDXG
TWNP
TWNP
Q4 25
$15.2M
Q3 25
$16.7M
$-24.5M
Q2 25
$9.6M
$-20.8M
Q1 25
$7.0M
$-12.1M
Q4 24
$7.4M
Q3 24
$8.1M
Q2 24
$17.6M
Q1 24
$9.3M
Gross Margin
MDXG
MDXG
TWNP
TWNP
Q4 25
83.9%
Q3 25
83.5%
Q2 25
81.1%
Q1 25
81.2%
Q4 24
81.8%
Q3 24
81.8%
Q2 24
83.0%
Q1 24
84.7%
Operating Margin
MDXG
MDXG
TWNP
TWNP
Q4 25
17.8%
Q3 25
19.5%
-16.2%
Q2 25
12.5%
-13.2%
Q1 25
9.4%
-1.2%
Q4 24
11.9%
Q3 24
13.3%
Q2 24
26.9%
Q1 24
15.6%
Net Margin
MDXG
MDXG
TWNP
TWNP
Q4 25
12.9%
Q3 25
14.7%
-29.7%
Q2 25
9.8%
-23.7%
Q1 25
8.0%
-13.9%
Q4 24
8.0%
Q3 24
9.6%
Q2 24
20.2%
Q1 24
10.9%
EPS (diluted)
MDXG
MDXG
TWNP
TWNP
Q4 25
$0.10
Q3 25
$0.11
$-0.43
Q2 25
$0.06
$-0.38
Q1 25
$0.05
$-0.26
Q4 24
$0.05
Q3 24
$0.05
Q2 24
$0.12
Q1 24
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MDXG
MDXG
TWNP
TWNP
Cash + ST InvestmentsLiquidity on hand
$166.1M
Total DebtLower is stronger
$18.0M
$402.8M
Stockholders' EquityBook value
$256.5M
$-92.1M
Total Assets
$342.7M
$516.8M
Debt / EquityLower = less leverage
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MDXG
MDXG
TWNP
TWNP
Q4 25
$166.1M
Q3 25
$142.1M
Q2 25
$118.9M
Q1 25
$106.4M
Q4 24
$104.4M
Q3 24
$88.8M
Q2 24
$69.0M
Q1 24
$48.5M
Total Debt
MDXG
MDXG
TWNP
TWNP
Q4 25
$18.0M
Q3 25
$402.8M
Q2 25
$411.3M
Q1 25
$413.0M
Q4 24
$19.0M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MDXG
MDXG
TWNP
TWNP
Q4 25
$256.5M
Q3 25
$238.9M
$-92.1M
Q2 25
$216.6M
$-78.6M
Q1 25
$202.8M
$-101.9M
Q4 24
$193.1M
Q3 24
$181.0M
Q2 24
$168.0M
Q1 24
$155.7M
Total Assets
MDXG
MDXG
TWNP
TWNP
Q4 25
$342.7M
Q3 25
$319.0M
$516.8M
Q2 25
$291.1M
$535.1M
Q1 25
$270.4M
$544.2M
Q4 24
$263.9M
Q3 24
$243.9M
Q2 24
$230.2M
Q1 24
$221.7M
Debt / Equity
MDXG
MDXG
TWNP
TWNP
Q4 25
0.07×
Q3 25
Q2 25
Q1 25
Q4 24
0.10×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MDXG
MDXG
TWNP
TWNP
Operating Cash FlowLast quarter
$25.0M
$-5.9M
Free Cash FlowOCF − Capex
$-7.4M
FCF MarginFCF / Revenue
-9.0%
Capex IntensityCapex / Revenue
1.9%
Cash ConversionOCF / Net Profit
1.64×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MDXG
MDXG
TWNP
TWNP
Q4 25
$25.0M
Q3 25
$29.3M
$-5.9M
Q2 25
$14.4M
$-8.8M
Q1 25
$5.3M
$-5.7M
Q4 24
$18.8M
Q3 24
$19.6M
Q2 24
$21.8M
Q1 24
$6.0M
Free Cash Flow
MDXG
MDXG
TWNP
TWNP
Q4 25
Q3 25
$-7.4M
Q2 25
$-10.6M
Q1 25
$-9.7M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
MDXG
MDXG
TWNP
TWNP
Q4 25
Q3 25
-9.0%
Q2 25
-12.1%
Q1 25
-11.2%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
MDXG
MDXG
TWNP
TWNP
Q4 25
Q3 25
1.9%
Q2 25
2.1%
Q1 25
4.6%
Q4 24
Q3 24
Q2 24
Q1 24
Cash Conversion
MDXG
MDXG
TWNP
TWNP
Q4 25
1.64×
Q3 25
1.75×
Q2 25
1.50×
Q1 25
0.75×
Q4 24
2.53×
Q3 24
2.42×
Q2 24
1.24×
Q1 24
0.65×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MDXG
MDXG

Wound$78.7M67%
Surgical$39.4M33%

TWNP
TWNP

Segment breakdown not available.

Related Comparisons